Medicare Enrolled
Dr. Aditya Sarvaria, MD
Internal Medicine · San Diego, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sarvaria from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarvaria?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sarvaria
Dr. Aditya Sarvaria is an internal medicine specialist in San Diego, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Sarvaria performed 13,550 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sarvaria received a total of $17,606 from 80 pharmaceutical and/or device companies across 744 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sarvaria is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 2% volume in CA
$17,606 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗13,550
Medicare services
Top 2% in CA for internal medicine
Not available
Unique patients (not deduplicated)
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (aprepitant) | 4,550 | $1 | $7 |
| Denosumab injection (Prolia/Xgeva) | 2,700 | $16 | $70 |
| Injection, granisetron hydrochloride, 100 mcg | 1,300 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,110 | $0 | $1 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,030 | $21 | $207 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
456 | $103 | $350 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
329 | $14 | $55 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
278 | $147 | $491 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
276 | $73 | $1,806 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
261 | $119 | $479 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
151 | $56 | $236 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
139 | $69 | $248 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
133 | $2 | $15 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
126 | $6 | $39 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
80 | $59 | $232 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
79 | $12 | $46 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
67 | $25 | $100 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
66 | $22 | $94 |
| New patient office visit, complex (60-74 min) | 52 | $175 | $598 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
46 | $24 | $110 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
44 | $27 | $114 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
37 | $65 | $187 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
37 | $272 | $4,702 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
33 | $26 | $104 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
28 | $1 | $6 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
26 | $18 | $70 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
24 | $18 | $72 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
22 | $2 | $10 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $98 | $269 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
18 | $11 | $44 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $123 | $453 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
16 | $1 | $41 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.5% high complexity
86.9% medium
8.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,606
Total received (2018-2024)
Avg $2,515/year across 7 years
Top 6% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
744
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,358
2023
$3,567
2022
$1,475
2021
$3,248
2020
$3,192
2019
$2,412
2018
$1,355
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$271
E.R. Squibb & Sons, L.L.C.
$245
Novartis Pharmaceuticals Corporation
$191
SOBI, INC
$139
Alexion Pharmaceuticals, Inc.
$133
PFIZER INC.
$132
Janssen Biotech, Inc.
$113
Merck Sharp & Dohme LLC
$108
PharmaEssentia USA Corporation
$93
Regeneron Healthcare Solutions, Inc.
$92
Agios Pharmaceuticals, Inc.
$86
Genentech USA, Inc.
$76
Celgene Corporation
$74
Eisai Inc.
$61
Daiichi Sankyo Inc.
$60
GlaxoSmithKline, LLC.
$52
Kite Pharma, Inc.
$39
Deciphera Pharmaceuticals Inc.
$33
Ipsen Biopharmaceuticals, Inc
$33
Gilead Sciences, Inc.
$31
Exelixis Inc.
$29
TAIHO ONCOLOGY, INC.
$29
SpringWorks Therapeutics, Inc.
$25
Coherus Biosciences Inc.
$25
EMD Serono, Inc.
$24
Incyte Corporation
$23
ABBVIE INC.
$23
Lilly USA, LLC
$19
Sumitomo Pharma America, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Tempus AI, Inc
$18
Blueprint Medicines Corporation
$14
GENZYME CORPORATION
$14
CSL Behring
$13
Top 3 companies account for 30.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,385
E.R. Squibb & Sons, L.L.C.
$2,174
Novartis Pharmaceuticals Corporation
$1,074
Merck Sharp & Dohme Corporation
$973
Amgen Inc.
$873
Celgene Corporation
$730
PFIZER INC.
$481
Alexion Pharmaceuticals, Inc.
$462
Astellas Pharma US Inc
$456
Pharmacyclics LLC, An AbbVie Company
$436
Daiichi Sankyo Inc.
$359
Genentech USA, Inc.
$326
Janssen Biotech, Inc.
$316
Exelixis Inc.
$303
Blueprint Medicines Corporation
$293
GlaxoSmithKline, LLC.
$283
Eisai Inc.
$259
Seagen Inc.
$250
Karyopharm Therapeutics Inc.
$246
Lilly USA, LLC
$233
Regeneron Healthcare Solutions, Inc.
$210
SOBI, INC
$193
Incyte Corporation
$186
EMD Serono, Inc.
$183
EISAI INC.
$183
Foundation Medicine, Inc.
$181
Kite Pharma, Inc.
$176
Clovis Oncology, Inc.
$158
Ipsen Biopharmaceuticals, Inc
$157
Takeda Pharmaceuticals U.S.A., Inc.
$152
Merck Sharp & Dohme LLC
$150
Bayer HealthCare Pharmaceuticals Inc.
$136
Puma Biotechnology, Inc.
$132
Gilead Sciences, Inc.
$129
GENZYME CORPORATION
$127
Rigel Pharmaceuticals, Inc.
$126
Janssen Pharmaceuticals, Inc
$110
Agios Pharmaceuticals, Inc.
$106
BeiGene USA, Inc.
$99
Stryker Corporation
$97
PharmaEssentia USA Corporation
$93
Pharmacyclics LLC, an AbbVie Company
$85
AMAG Pharmaceuticals, Inc.
$77
ADC Therapeutics America, Inc.
$75
PUMA BIOTECHNOLOGY, INC.
$73
AbbVie Inc.
$73
Dova Pharmaceuticals
$70
G1 Therapeutics, Inc.
$66
ARRAY BIOPHARMA INC
$63
Bayer Healthcare Pharmaceuticals Inc.
$62
Kyowa Kirin, Inc.
$61
TAIHO ONCOLOGY, INC.
$57
Seattle Genetics, Inc.
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Sun Pharmaceutical Industries Inc.
$53
Genmab U.S., Inc.
$49
TerSera Therapeutics LLC
$47
AVEO Pharmaceuticals, Inc.
$45
Mylan Institutional Inc.
$40
Acrotech Biopharma LLC
$38
Sobi, Inc
$35
ABBVIE INC.
$35
Stemline Therapeutics Inc.
$34
Deciphera Pharmaceuticals Inc.
$33
AbbVie, Inc.
$31
Taiho Oncology, Inc.
$29
CSL Behring
$28
SpringWorks Therapeutics, Inc.
$25
Coherus Biosciences Inc.
$25
Servier Pharmaceuticals LLC
$22
Epizyme, Inc.,
$21
Mirati Therapeutics, Inc.
$19
Sumitomo Pharma America, Inc.
$19
Sirtex Medical Inc
$18
Tempus AI, Inc
$18
Advanced Accelerator Applications
$17
Otsuka America Pharmaceutical, Inc.
$14
Aurobindo Pharma USA, Inc.
$14
West Therapeutics Development, LLC
$14
Array BioPharma Inc.
$14
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · ASPARLAS · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CREON · CRESEMBA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · Epkinly · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · Fabhalta · Fulphila · GAVRETO · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Idelvion · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NOXAFIL · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · OPTABLATE · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · Tavalisse · Tecentriq · Trodelvy · Turalio · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · YERVOY · YONSA · Yescarta · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
1,628
County median income
$102,285
Nearest hospital to ZIP centroid (approximate)
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sarvaria is a mixed practice specialist, with above-average Medicare volume (top 2% in CA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sarvaria experienced with anti-nausea injection (aprepitant)?
Based on Medicare claims data, Dr. Sarvaria performed 4,550 anti-nausea injection (aprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sarvaria receive payments from pharmaceutical companies?
Yes. Dr. Sarvaria received a total of $17,606 from 80 companies across 744 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarvaria's costs compare to other internal medicine physicians in San Diego?
Dr. Sarvaria's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarvaria) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in San Diego
Browse internal medicine physicians in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology